{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:59:19Z","timestamp":1789747159762,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jpba.2017.11.028","type":"journal-article","created":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T22:30:23Z","timestamp":1510353023000},"page":"351-357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Sulfaguanidine cocrystals: Synthesis, structural characterization and their antibacterial and hemolytic analysis"],"prefix":"10.1016","volume":"149","author":[{"given":"Syed Sibte Asghar","family":"Abidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser","family":"Azim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahper Nazeer","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asad U.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jpba.2017.11.028_bib0005","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1039\/C5CC08216A","article-title":"Pharmaceutical cocrystals: along the path to improved medicines","volume":"52","author":"Duggirala","year":"2016","journal-title":"Chem. Commun."},{"issue":"1-2","key":"10.1016\/j.jpba.2017.11.028_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2011.07.037","article-title":"Pharmaceutical cocrystals: an overview","volume":"419","author":"Qiao","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"54","key":"10.1016\/j.jpba.2017.11.028_bib0015","doi-asserted-by":"crossref","first-page":"8342","DOI":"10.1039\/C6CC02943D","article-title":"Pharmaceutical cocrystals: walking the talk","volume":"52","author":"Bolla","year":"2016","journal-title":"Chem. Commun."},{"issue":"9","key":"10.1016\/j.jpba.2017.11.028_bib0020","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.drudis.2008.03.004","article-title":"The role of cocrystals in pharmaceutical science","volume":"13","author":"Shan","year":"2008","journal-title":"Drug Discovery Today."},{"key":"10.1016\/j.jpba.2017.11.028_bib0025","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1021\/cg900129f","article-title":"Pharmaceutical cocrystals and their physicochemical properties","volume":"9","author":"Schultheiss","year":"2009","journal-title":"Cryst. Growth. Des."},{"key":"10.1016\/j.jpba.2017.11.028_bib0030","first-page":"1","article-title":"Improving biopharmaceutical properties of vinpocetine through cocrystallization","author":"Golob","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2017.11.028_bib0035","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1021\/acs.cgd.6b01769","article-title":"Cocrystals of hesperetin: structural, pharmacokinetic, and pharmacodynamic evaluation","volume":"17","author":"Chadha","year":"2017","journal-title":"Cryst. Growth. Des."},{"key":"10.1016\/j.jpba.2017.11.028_bib0040","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1021\/acs.molpharmaceut.5b00020","article-title":"Cocrystals of Hydrochlorothiazide: solubility and diffusion\/permeability enhancements through drug-coformer interactions Cocrystals of Hydrochlorothiazide: solubility and diffusion\/permeability enhancements through drug-coformer interactions","volume":"12","author":"Sanphui","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jpba.2017.11.028_bib0045","article-title":"Tablet formulation and enhancement of aqueous solubility of efavirenz by solvent evaporation Co-Crystal technique","author":"Rajurkar","year":"2015","journal-title":"Med. Chem."},{"key":"10.1016\/j.jpba.2017.11.028_bib0050","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1021\/acs.cgd.7b00144","article-title":"Reducing the hygroscopicity of the anti-Tuberculosis drug (S, S) ethambutol using multicomponent crystal forms","volume":"17","author":"Diniz","year":"2017","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.jpba.2017.11.028_bib0055","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1021\/cg201510n","article-title":"Cocrystal systems of pharmaceutical interest","volume":"12","author":"Brittain","year":"2012","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.jpba.2017.11.028_bib0060","series-title":"Development and Manufacture of Drug Substances (Chemical Entities and Biotechnological\/Biological Entities)","first-page":"Q11","author":"ICH","year":"2012"},{"key":"10.1016\/j.jpba.2017.11.028_bib0065","series-title":"Reflection Paper on the Use of Cocrsytals of Active Substances in Medicinal Products","author":"EMA","year":"2015"},{"key":"10.1016\/j.jpba.2017.11.028_bib0070","series-title":"Stability Testing of New Drug Substances and Products","first-page":"Q1A","author":"ICH","year":"2017"},{"issue":"5","key":"10.1016\/j.jpba.2017.11.028_bib0075","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1021\/mp500826y","article-title":"Indomethacin co-crystals and their parent mixtures: does the intestinal barrier recognize them differently?","volume":"12","author":"Ferretti","year":"2015","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.jpba.2017.11.028_bib0080","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1002\/jps.22434","article-title":"Coformer selection in pharmaceutical cocrystal development: a case study of a meloxicam aspirin cocrystal that exhibits enhanced solubility and pharmacokinetics","volume":"100","author":"Cheney","year":"2011","journal-title":"J. Pharm Sci."},{"key":"10.1016\/j.jpba.2017.11.028_bib0085","first-page":"163","volume":"67","author":"Marshall","year":"1940","journal-title":"Bull. Johns Hopkins Hosp."},{"key":"10.1016\/j.jpba.2017.11.028_bib0090","first-page":"161","volume":"7","author":"Keiter","year":"1940"},{"key":"10.1016\/j.jpba.2017.11.028_bib0095","first-page":"149","article-title":"DFT studies on the IR spectral and structural changes arising from the conversion of 4-amino-N- [amino (imino) methyl] benzenesulfonamide (sulfaguanidine) into azanion","volume":"46","author":"Popova","year":"2014","journal-title":"Bulgarian Chemical Communications"},{"key":"10.1016\/j.jpba.2017.11.028_bib0100","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1021\/ja01865a027","article-title":"Chemotherapy. I. substituted sulfanilamidopyridines","volume":"62","author":"Roblin","year":"1940","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.jpba.2017.11.028_bib0105","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0002-9610(42)90665-2","article-title":"The use of sulfaguanidine as an intestinal antiseptic","volume":"58","author":"Vieta","year":"1942","journal-title":"Am. J. Surg."},{"issue":"3","key":"10.1016\/j.jpba.2017.11.028_bib0110","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0022-3476(42)80188-2","article-title":"The use of sulfaguanidine in enteric infections","volume":"20","author":"Hall","year":"1942","journal-title":"J. Pediatr."},{"key":"10.1016\/j.jpba.2017.11.028_bib0115","first-page":"5I","article-title":"Chemotherapy in acute baciIIary dysentery Part II. CIinicaI use of sulfanilylguanidine West. va","volume":"37","author":"Lyon","year":"1941","journal-title":"Med. J."},{"issue":"20","key":"10.1016\/j.jpba.2017.11.028_bib0120","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1039\/b207369m","article-title":"Mechanochemistry and co-crystal formation: effect of solvent on reaction kinetics","volume":"1","author":"Shan","year":"2002","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jpba.2017.11.028_bib0125","series-title":"CrysAlisPro Program Version171.37.33c","year":"2012"},{"key":"10.1016\/j.jpba.2017.11.028_bib0130","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1107\/S0021889808042726","article-title":"OLEX2. A complete structure solution, refinement and analysis program","volume":"42","author":"Dolomanov","year":"2009","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.jpba.2017.11.028_bib0135","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1107\/S0108768189012929","article-title":"Graph set analysis of hydrogen bond patterns in organic crystals","volume":"46","author":"Etter","year":"1990","journal-title":"Acta Crystallogr Sect B."},{"key":"10.1016\/j.jpba.2017.11.028_bib0140","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.colsurfb.2015.07.009","article-title":"Biointerfaces Gelatin-based nanoparticles as DNA delivery systems: synthesis, physicochemical and biocompatible characterization","volume":"134","author":"Mor\u00e1n","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jpba.2017.11.028_bib0145","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2174\/1874126600701010007","article-title":"Rationally designed synthetic vectors for gene delivery","volume":"1","author":"Rao","year":"2007","journal-title":"Open Drug Delivery"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708517322380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708517322380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T08:16:18Z","timestamp":1536308178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708517322380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":29,"alternative-id":["S0731708517322380"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2017.11.028","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sulfaguanidine cocrystals: Synthesis, structural characterization and their antibacterial and hemolytic analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2017.11.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}